XK
TMO icon

Xact Kapitalforvaltning’s Thermo Fisher Scientific TMO Stock Holding History

Xact Kapitalforvaltning’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$25.5M Buy
90,002
+185
+0.2% +$58.3K 0.54% 37
2019
Q4 		$29.2M Buy
89,817
+840
+0.9% +$255K 0.5% 38
2019
Q3 		$25.9M Buy
88,977
+6,294
+8% +$1.8M 0.49% 36
2019
Q2 		$24.3M Buy
82,683
+5,204
+7% +$1.43M 0.5% 39
2019
Q1 		$21.2M Buy
77,479
+2,357
+3% +$587K 0.48% 42
2018
Q4 		$16.8M Sell
75,122
-12,489
-14% -$2.93M 0.43% 44
2018
Q3 		$21.4M Sell
87,611
-2,455
-3% -$565K 0.45% 40
2018
Q2 		$18.7M Buy
90,066
+405
+0.5% +$86K 0.4% 45
2018
Q1 		$18.5M Buy
89,661
+3,707
+4% +$778K 0.42% 44
2017
Q4 		$16.3M Buy
85,954
+5,509
+7% +$1.06M 0.39% 47
2017
Q3 		$15.2M Buy
80,445
+680
+0.9% +$123K 0.44% 46
2017
Q2 		$13.9M Buy
79,765
+867
+1% +$146K 0.42% 46
2017
Q1 		$12.1M Buy
78,898
+1,671
+2% +$255K 0.37% 56
2016
Q4 		$10.9M Buy
77,227
+1,460
+2% +$215K 0.38% 54
2016
Q3 		$12.1M Buy
+75,767
New +$11.7M 0.43% 48

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Xact Kapitalforvaltning's TMO Position: Q1 2020 in Review

Xact Kapitalforvaltning increased its Thermo Fisher Scientific (TMO) stake by 0.21% in Q1 2020, buying an estimated $58.3K and bringing the position to 90,002 shares worth $25.5M. The position accounts for 0.54% of the portfolio, ranked #37.

Xact Kapitalforvaltning first reported a position in TMO in Q3 2016 and has held it in 15 quarters since. The position peaked at $29.2M in Q4 2019. 1,675 funds tracked by Wall St. Rank hold TMO as of Q1 2020.

  • Xact Kapitalforvaltning held 90,002 shares of Thermo Fisher Scientific worth $25.5M as of Q1 2020.
  • Xact Kapitalforvaltning bought 185 Thermo Fisher Scientific shares in Q1 2020, an estimated $58.3K.
  • Thermo Fisher Scientific made up 0.54% of Xact Kapitalforvaltning's portfolio in Q1 2020, its #37 holding.
  • Xact Kapitalforvaltning first reported a position in Thermo Fisher Scientific in Q3 2016 and has held it in 15 quarters since.
  • Xact Kapitalforvaltning's Thermo Fisher Scientific position peaked at $29.2M in Q4 2019.
  • 1,675 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2020.

Based on Xact Kapitalforvaltning's 13F filing for Q1 2020, filed 14 May 2020.